The U.S. Department of Justice (DOJ) has rejected the sale of Amedisys’ (Nasdaq: AMED) home health and hospice assets to BrightSpring Health Services Inc. (Nasdaq: BTSG) and The Pennant Group (Nasdaq: PNTG) as a remedy to an ongoing lawsuit. Amedisys earlier this month announced the divestiture of a number of its home health and hospice locations to several companies, including affiliates of BrightSpring and Pennant. The deal was aimed at addressing the DOJ’s antitrust concerns related to the sale of Amedisys to UnitedHealth Group’s (NYSE: UNH) health care subsidiary Optum.
Read the full article: DOJ Rejects Amedisys, UnitedHealth’s Divestiture to BrightSpring, Pennant //
Source: https://hospicenews.com/2025/05/12/doj-rejects-amedisys-unitedhealths-divestiture-to-brightspring-pennant/